The management of primary hyperparathyroidism

Clinical Endocrinology

Volumn 57, Issue 2, 2002, Pages 145-155

  Davies, M ^a   Fraser, W D ^b   Hosking, D J ^c,d  

^a MANCHESTER ROYAL INFIRMARY   (United Kingdom)

^b ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

^c NOTTINGHAM CITY HOSPITAL   (United Kingdom)

^d NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL; CALCIUM; CALCIUM CHANNEL STIMULATING AGENT; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; PARATHYROID HORMONE;

ACUTE PANCREATITIS; BONE DENSITY; BONE MINERAL; CALCIUM BLOOD LEVEL; CARDIOVASCULAR EFFECT; COMPUTER ASSISTED TOMOGRAPHY; CONSERVATIVE TREATMENT; ECHOGRAPHY; EVALUATION; FOLLOW UP; HORMONE SUBSTITUTION; HUMAN; HYPERCALCEMIA; HYPOCALCEMIA; LARYNGEAL NERVE; LIFE EXPECTANCY; NEPHROLITHIASIS; NERVE INJURY; NUCLEAR MAGNETIC RESONANCE IMAGING; PARATHYROID GLAND; PARATHYROID SCINTISCANNING; PARATHYROIDECTOMY; POSTOPERATIVE CARE; PRIMARY HYPERPARATHYROIDISM; PRIORITY JOURNAL; REVIEW; RISK; SCINTISCANNING; TREATMENT INDICATION;

BONE DENSITY; CALCIUM; HUMANS; HYPERPARATHYROIDISM; HYPERTENSION; KIDNEY CALCULI; LIFE EXPECTANCY; PARATHYROID HORMONE; PARATHYROIDECTOMY; PATIENT SELECTION; POSTOPERATIVE PERIOD;

EID: 0036377082     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.2002.01581.x     Document Type: Review

References (101)

1. Bone mineral recovery after parathyroidectomy in patients with primary and renal hyperparathyroidism
2. Parathyroidectomy for primary hyperparathyroidism induces positive uncoupling and increases bone mineral density in cancellous bones
3. Bone measurements in asymptomatic primary hyperparathyroidism
4. Calcium-induced natriuresis: Physiologic and clinical implications
5. The evolution of parathyroidectomy failures
6. Serum calcium survey for hyperparathyroidism: Results in 50000 clinic patients
7. Comparison of two diets for the prevention of recurrent stones in idiopathic hypercalciuria
8. Technetium-99m sestamibi parathyroid localisation is accurate enough for scan-directed unilateral neck exploration
9. The importance of circulating 1,25-dihydroxyvitamin D in the pathogenesis of hypercalciuria and renal-stone formation in primary hyperparathyroidism
10. Concise parathyroidectomy: The impact of preoperative SPECT 99mTc sestamibi scanning and intra-operative quick parathormone assay
11. Bilateral oblique approach to parathyroid glands
12. Outpatient minimally invasive parathyroidectomy: A combination of sestamibi-SPECT localisation, cervical block anesthesia, and intraoperative parathyroid hormone assay
13. Primary hyperpara-thyroidism: Biochemical markers and bone mineral density at multiple skeletal sites in Danish patients
14. Primary hyperparathyroidism: Effect of parathyroidectomy on regional bone mineral density in Danish patients - A three year follow-up study
15. Primary hyperparathyroidism: Iliac crest cortical thickness, structure and remodeling evaluated by histomorphometric methods
16. Primary hyperparathyroidism: Iliac crest trabecular bone volume, structure, remodeling and balance evaluated by histomorphometric methods
17. Surgical treatment of primary hyperparathyroidism
18. Back pain and vertebral crush fractures. An unemphasized mode of presentation for primary hyperparathyroidism
19. Familial hypocalcaemic hypercalcaemia and acute pancreatitis
20. The effect of parathyroidectomy on the recurrence of nephrolithiasis
21. Minimally invasive parathyroidectomy: 50 Cases
22. Surgery for primary hyperparathyroidism 1962-1996: Indications and outcome
23. Cost-effectiveness of preoperative sestamibi scan for primary hyperparathyroidism is dependent solely upon the surgeon's choice of operative procedure
24. Blood pressure, left ventricular mass and intracellular calcium in primary hyperparathyroidism
25. Localisation of parathyroid tumours in patients with asymptomatic hyperparathyroidism and no previous surgery
26. Minimally invasive video-assisted parathyroidectomy - Selective approach to localised single gland adenoma
27. Parathyroid hormone deficiency and excess: Similar effects on trabecular bone but differing effects on cortical bone
28. Immunochemiluminometric and immunoradiometric determinations of intact and total immunoreactive parathyrin: Performance in the differential diagnosis of hypercalcaemia and hypoparathyroidism
29. Minimally invasive radioguided parathyroidectomy
30. Clinical and laboratory studies of a new immunoradiometric assay of parathyroid hormone-related protein
31. Development of a novel immunoradiometric assay exclusively for biologically active whole parathyroid hormone 1-84: Implications for improvement of accurate assessment of parathyroid function
32. Initial experience with intra-operative PTH determinations in the surgical management of 130 cases of primary hyperparathyroidism
33. Endoscopically assisted, minimally invasive parathyroidectomy
34. Effect of minimally invasive radioguided parathyroidectomy on efficacy, length of stay, and costs in the management of primary hyperparathyroidism
35. Massive subcutaneous emphysema and severe hypercarbia in a patient during endoscopic transcervical parathyroidectomy using carbon dioxide insufflation
36. Is sestamibi-guided parathyroidectomy really cost-effective?
37. Longitudinal changes in bone mineral density and bone turnover in postmenopausal women with primary hyperpara-thyroidism
38. Indications, technique and efficacy of alcohol injection of enlarged parathyroid glands in patients with primary hyperparathyroidism
39. Surgical treatment of primary hyperparathyroidism in the elderly
40. Increased risk of death from primary hyperparathyroidism - An update
41. Improvement of muscle strength after treatment for hyperparathyroidism
42. Survival in hypercalcaemic patients with cancer and co-existing primary hyperparathyroidism
43. Unilateral neck exploration under local anesthesia: The approach choice for asymptomatic primary hyperparathyroidism
44. Improved success rate in reoperative parathyroidectomy with intra-operative PTH assay
45. Localisation of parathyroid glands in hemodialysis patients using Tc-99m sestamibi imaging
46. Primary hyperparathyroidism in patients with organic brain syndrome
47. Self-rated psychiatric symptoms in patients operated on because of primary hyperparathyroidism and in patients with long standing mild hypercalcaemia
48. Maximal isokinetic muscle strength in patients with primary hyperparathyroidism before and after parathyroid surgery
49. Changes in blood pressure and renal function after parathyroidectomy in primary hyperparathyroidism
50. Prognosis of parathyroid function after successful percutaneous ethanol injection therapy guided by color Doppler flow mapping in chronic dialysis patients
51. Fracture incidence in postmenopausal women with primary hyperparathyroidism
52. Primary hyperparathyroidism and the risk of fracture: A population based study
53. What is the clinical significance of bone loss in primary hyperparathyroidism?
54. Increased fracture risk in hypercalcaemia: Bone mineral content measured in hyperparathyroidism
55. The risk of hip fractures in patients with primary hyperparathyroidism: A population-based cohort study with a follow-up of 19 years
56. A non-(1-84) circulating parathyroid hormone (PTH) fragment interferes significantly with intact PTH commercial assay measurements in uremic samples
57. The reasons for failure in parathyroidism operations
58. Bilateral neck exploration for parathyroidectomy under local anesthesia: A viable technique for patients with coexisting thyroid disease with or without sestamibi scanning
59. Parathyroidectomy via bilateral cervical exploration: A retrospective review of 866 cases
60. Secondary hyperparathyroidism is an expected consequence of parathyroidectomy for primary hyperparathyroidism: A prospective study
61. Partially reversible osteopaenia after surgery for primary hyperparathyroidism
62. Endoscopic parathyroidectomy: Report of an initial experience
63. Intrinsic limitations to unilateral parathyroid exploration
64. Diagnostic strategies and surgical procedures in persistent or recurrent primary hyperparathyroidism
65. Endoscopic endocrine surgery in the neck: An initial report of endoscopic subtotal parathyroidectomy
66. Consensus development conference statement on primary hyperparathyroidism
67. Calcimimetics with potent and selective activity on the parathyroid calcium receptor
68. 99mTc - Sestamibi subtraction single photon emission compute tomography
69. Successful parathyroidectomy in primary hyperparathyroidism: A clinical follow-up study of 212 consecutive patients
70. Minimally invasive radioguided parathyroidectomy in the reoperative neck
71. The false-positive parathyroid sestamibi: A real or perceived problem and a case for radioguided parathyroidectomy
72. Highly sensitive two-site immunoradiometric assay of parathyrin and its clinical utility in evaluating patients with hypercalcemia
73. Effects of hormone replacement therapy on bone mineral density in postmenopausal women with primary hyperparathyroidism: Four year follow-up and comparison with healthy postmenopausal women
74. Photon absorptiometric analysis of bone density in primary hyperparathyroidism
75. Survival and renal function in untreated hypercalcaemia
76. Pancreatitis associated with primary hyperparathyroidism
77. Asymptomatic primary hyperparathyroidism discovered by multi-channel biochemical screening: Clinical course and considerations bearing on the need for surgical intervention
78. Neuro-muscular disease in primary hyperparathyroidism
79. Left ventricular hypertrophy in primary hyperparathyroidism. Effects of successful parathyroidectomy
80. Primary surgery for hyperparathyroidism: The lateral approach after preoperative ultrasonographic localisation
81. Minimally invasive surgery for primary hyperparathyroidism: Systematic review
82. Bone mineral changes in primary hyperparathyroidism
83. Reoperative parathyroidectomy in the era of localisation technology
84. Hypertension and renal dysfunction in primary hyperparathyroidism: Effect of parathyroidectomy
85. Sestamibi scanning is inadequate for directing unilateral neck exploration for first-time parathyroidectomy
86. Primary hyperparathyroidism: Still evolving?
87. Short term inhibition of parathyroid hormone secretion by a calcium-receptor agonist in patients with primary hyperparathyroidism
88. Longitudinal measurements of bone density and biochemical indices in untreated primary hyperparathyroidism
89. Increased bone mineral density following parathyroidectomy in primary hyperparathyroidism
90. A 10 year prospective study of primary hyperparathyroidism with or without parathyroid surgery
91. Direct, minimally invasive adenomectomy for primary hyperparathyroidism: An alternative to conventional neck exploration?
92. Profile of a clinical practice: Threshold for surgery and surgical outcomes for patients with primary hyperparathyroidism: A national survey of endocrine surgeons
93. Cardiac abnormalities in patients with primary hyperparathyroidism: Implications for follow-up
94. Time course of regression of left ventricular hypertrophy after successful parathyroidectomy
95. Primary hyperparathyroidism: Bone structure, balance and remodelling before and 3 years after surgical treatment
96. Clinical assessment of collagen cross-linked N-telopeptides as a marker of bone metabolism in patients with primary hyperparathyroidism
97. The role of preoperative thallium-technetium subtraction scintigraphy in the surgical management of patients with solitary parathyroid adenoma
98. Neuromuscular involvement in mild, asymptomatic primary hyperparathyroidism
99. Unilateral parathyroid exploration
100. Survival after the diagnosis of hyperparathyroidism: A population based study
101. Novel serum markers of bone resorption: Clinical assessment and comparison with established urinary indices